Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Correction of presbyopia at cataract surgery with polyfocal intraocular lens WIOL-CF: one year experience

Poster Details

First Author: M.Ilavska SLOVAKIA

Co Author(s):                        

Abstract Details

Purpose:

Clinical evaluation of functional results and quality of vision after the bilateral cataract surgery with implantation of a bioanalogic, polyfocal intraocular lens.

Setting:

Medilux Eye Centrum, Galanta , Slovak Republic

Methods:

The cataract surgery was done by incision 2.75 mm, capsulorhexis 6 mm, implantation by injector in to the capsular bag. Binocular uncorrected visual acuity (UNVA) was evaluated for distance, intermediate (70 cm) and near ( 40 cm) on reading tables. The contrast sensitivity was examinated by the Pelli-Robson test. The quality of vision , spectacle independence and personal satisfaction of patients was assessed by completing a questionnaire ( the Visual function test NEI - VFQ14).

Results:

13 patients,(26 eyes), underwent uneventful cataract surgery during the period 06/2013 – 12/2014. Mean binocular UNVA 3 month after surgery was 0.895 (Snellen optotyps) (range 0.63-1.0). Binocular UNVA for 70 cm was 0.16 log MAR and for 40 cm 0. 22 log MAR. The mean binocular contrast sensitivity was 2.69%, (average logCS 1.575) for the size of letters 4/125. Any patient with binocular implantation of WIOL –CF need a spectacles for daily activities, driving and reading. Two patients gave an account of light phenomenon at night.

Conclusions:

Clinical results are very promising. Lens provides 100% spectacle independence on all distances and excellent contrast sensitivity with low level of optical phenomena and high subjective satisfaction of patients. The next following of the stability of results is necessary.

Financial Disclosure:

NONE

Back to Poster listing